Publication | Open Access

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group

Hematological MalignancyLymphoid NeoplasiaOncologyCase Control StudyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyGenetic EpidemiologyPathologyImmunologyMedium Risk FeaturesMolecular DiagnosticsCancer ResearchMinimal Residual Disease